The Health Care Select Sector SPDR Fund, known by its ticker XLV, remains up more than 10 percent this year, while the S&P 500 Index erased gains. (Photo: Shutterstock)
(Bloomberg) –Health-care investors may have to be a bit more selective than they're used to in 2019.
With U.S. health stocks poised to wrap up their second straight year of outperforming the broader market, the focus on hunting for innovation and next year's winners is even more in vogue after recent market volatility.
Small- to mid-cap biotechnology darlings that saw shares surge amid a seemingly never-ending bull market have been punished and high-flying device makers ran cold, causing some investors to sell out of positions hand over fist.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
